Dupixent, a Sanofi and Regeneron Pharmaceuticals drug, is now approved for chronic obstructive pulmonary disease (COPD), a progressive lung disease prevalent in smokers. It’s the sixth FDA-approved indication for the blockbuster drug. The post Sanofi and Regeneron Biologic Drug Dupixent Notches a New FDA Approval in COPD appeared first on MedCity News.
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in “anticompetitive and unfair rebating practices” as it relates to insulin. One legal expert believes the FTC might win this legal battle. The post The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful? appeared first…
What will happen in the fall remains to be seen, but the pledge is facilitating an open dialogue within the senior care industry about the problems it’s facing, along with some fresh thinking on potential solutions. The post The Harris Campaign is Right to Pledge More Resources For Senior Home Care, But the Devil Will…
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) is considering certain changes to the current meningococcal vaccination schedule. Here’s why the ACIP should scrap that proposal. The post Protecting Our Future: Why We Must Guard Against Gaps in Public Health appeared first on MedCity News.
The new generation of healthcare AI innovation is promising, but there are some problems that remain when it comes to AI, such as data generalization and the high cost of adopting new tools, pointed out Dr. Arash Harzand. The post AI Holds Promise, But Concerns Around Costs and Data Remain appeared first on MedCity News.
Bristol Myers Squibb’s Cobenfy treats schizophrenia by going after a different target than currently available antipsychotic drugs, which is intended to offer better efficacy and safety. The drug came from the pharma giant’s $14 billion acquisition of Karuna Therapeutics. The post FDA Approval of Bristol Myers Drug Makes It the First Novel Schizophrenia Med in…
Pomelo Care recently acquired The Doula Network. Through the acquisition, Pomelo’s patients can now be matched with a community-based doula. The post Pomelo Care Acquires The Doula Network to Link Patients with Community-Based Doulas appeared first on MedCity News.
Artificial intelligence (AI) holds potential to forecast and predict where hospital leaders should direct limited resources such as clinicians, staff, and beds to improve operational efficiency and drive better patient outcomes. The post How AI Can Help Hospitals Overcome Patient Flow Barriers appeared first on MedCity News.
Precision medicine relies on understanding how differences affect drug response. Researchers can develop more precise treatments that are effective for more patients when prioritizing diversity. The post Why Accessible, Worldwide Biomanufacturing Solutions are Paramount appeared first on MedCity News.